482 related articles for article (PubMed ID: 14962901)
1. Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.
Brun AC; Björnsson JM; Magnusson M; Larsson N; Leveén P; Ehinger M; Nilsson E; Karlsson S
Blood; 2004 Jun; 103(11):4126-33. PubMed ID: 14962901
[TBL] [Abstract][Full Text] [Related]
2. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.
Björnsson JM; Larsson N; Brun AC; Magnusson M; Andersson E; Lundström P; Larsson J; Repetowska E; Ehinger M; Humphries RK; Karlsson S
Mol Cell Biol; 2003 Jun; 23(11):3872-83. PubMed ID: 12748289
[TBL] [Abstract][Full Text] [Related]
3. Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis.
Hills D; Gribi R; Ure J; Buza-Vidas N; Luc S; Jacobsen SE; Medvinsky A
Blood; 2011 Mar; 117(13):3521-8. PubMed ID: 21278354
[TBL] [Abstract][Full Text] [Related]
4. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.
Antonchuk J; Sauvageau G; Humphries RK
Exp Hematol; 2001 Sep; 29(9):1125-34. PubMed ID: 11532354
[TBL] [Abstract][Full Text] [Related]
5. NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4.
Zhu J; Giannola DM; Zhang Y; Rivera AJ; Emerson SG
Blood; 2003 Oct; 102(7):2420-7. PubMed ID: 12791656
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells.
Bijl J; Thompson A; Ramirez-Solis R; Krosl J; Grier DG; Lawrence HJ; Sauvageau G
Blood; 2006 Jul; 108(1):116-22. PubMed ID: 16339407
[TBL] [Abstract][Full Text] [Related]
7. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size.
Thorsteinsdottir U; Sauvageau G; Humphries RK
Blood; 1999 Oct; 94(8):2605-12. PubMed ID: 10515864
[TBL] [Abstract][Full Text] [Related]
8. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
10. HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.
Fournier M; Lebert-Ghali CÉ; Bijl JJ
Stem Cells Dev; 2015 Oct; 24(20):2413-22. PubMed ID: 26166023
[TBL] [Abstract][Full Text] [Related]
11. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells.
Lu SJ; Feng Q; Ivanova Y; Luo C; Li T; Li F; Honig GR; Lanza R
Stem Cells Dev; 2007 Aug; 16(4):547-59. PubMed ID: 17784829
[TBL] [Abstract][Full Text] [Related]
12. Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects.
Magnusson M; Brun AC; Lawrence HJ; Karlsson S
Exp Hematol; 2007 Sep; 35(9):1421-8. PubMed ID: 17761289
[TBL] [Abstract][Full Text] [Related]
13. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.
Kyba M; Perlingeiro RC; Daley GQ
Cell; 2002 Apr; 109(1):29-37. PubMed ID: 11955444
[TBL] [Abstract][Full Text] [Related]
14. A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning.
van Os R; Kamminga LM; Ausema A; Bystrykh LV; Draijer DP; van Pelt K; Dontje B; de Haan G
Stem Cells; 2007 Apr; 25(4):836-43. PubMed ID: 17170062
[TBL] [Abstract][Full Text] [Related]
15. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells.
Buske C; Feuring-Buske M; Abramovich C; Spiekermann K; Eaves CJ; Coulombel L; Sauvageau G; Hogge DE; Humphries RK
Blood; 2002 Aug; 100(3):862-8. PubMed ID: 12130496
[TBL] [Abstract][Full Text] [Related]
16. Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells.
Shaikh A; Bhartiya D; Kapoor S; Nimkar H
Stem Cell Res Ther; 2016 Apr; 7(1):59. PubMed ID: 27095238
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.
Watts KL; Zhang X; Beard BC; Chiu SY; Trobridge GD; Humphries RK; Kiem HP
Hum Gene Ther; 2011 Dec; 22(12):1475-82. PubMed ID: 21787196
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.
Helgason CD; Sauvageau G; Lawrence HJ; Largman C; Humphries RK
Blood; 1996 Apr; 87(7):2740-9. PubMed ID: 8639890
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
20. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.
Antonchuk J; Sauvageau G; Humphries RK
Cell; 2002 Apr; 109(1):39-45. PubMed ID: 11955445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
